Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia.
Slappendel
Robert
R
Department of Anesthisiology, Sint Maartenskliniek, Nijmegen, The Netherlands. r.slappendel@maartenskliniek.nl
Huvers
Frank C
FC
Benraad
Bart
B
Novàkova
Irena
I
van Hellemondt
Gijs G
GG
D019644:Arthroplasty, Replacement, Hip; D015942:Factor VIIa / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood*; D008875:Middle Aged; D019106:Postoperative Hemorrhage / Q000517:prevention & control*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013917:Thrombin / Q000096:biosynthesis; D013921:Thrombocytopenia / Q000097:blood*
D011994:Recombinant Proteins; D015942:Factor VIIa; D013917:Thrombin